HomeHeroesDe NovoDiscoveryGene ScanCDx Pathway♻️ Repurposing🚦 GatesModelsQuantum🧪 Wet LabSchedules🎛️ Control🧬 CIFOG📈 Milestones🧬 BioBrain🧠 NPEADArchitecture🔬 RODE🧠 Cortex-RWorkspace🧠 V2🧠 V3📦 Knowledge💰 Revenue🧪 Tests📊 Costs📚 Datasets

🧬 PIWIL2 — Discovery Report

📄 Autonomous discovery by Cortex · 2026-05-21

GenePIWIL2
Full NamePiwi Like RNA-Mediated Gene Silencing 2
Target ProteinPIWIL2_protein
Cancer TypeProstate / Pancreatic
GradeA+
PriorityHIGH
Stagelead_candidate
NoveltyFIRST-IN-CLASS (0 ChEMBL)
🧬 BioBrain⚖️ Decisions

Scientific Hypothesis

"PIWIL2 maintains cancer stem cell populations through piRNA-mediated epigenetic silencing. Inhibiting PIWIL2 depletes the therapy-resistant stem cell pool."

Mechanism of Action

Pathway: PIWIL2 → piRNA → transposon silencing → stem cell maintenance

Clinical Angle: Eliminate cancer stem cells driving recurrence

Docking Results

MetricValue
Best Vina Score-8.8 kcal/mol
Best Molecule (SMILES)O=C(Cc1ccc2ncccc2c1)Nc1ccc(C(=O)O)c(F)c1
Molecular Weight358.4 Da
QED / DCSAL0.782
Molecules Tested31
Docking Methodsmina (real GPU, g4dn.xlarge)
Receptor SourceAlphaFold v4

5-Dimension Scoring

🎯 Binding: 0.88 🔬 Pathway: 0.86 💡 Innovation: 0.95 💊 Therapy: 0.88 ⭐ Novelty: 1.0 🧬 BioBrain⚖️ Decisions

Total Score: —

CDx / Diagnostic Potential

Diagnostic: ectopic PIWIL2 expression = cancer stem cell presence. Prognostic: high PIWIL2 = recurrence risk.

Governance

PQM StatusISSUED
QCM Trust1.0
Ledger Logged✅ SHA-256 hash chain
Evidence IDRO-PIWIL2
Authoritymarcus_60 (sole override)

Conclusion

PIWIL2 is a FIRST-IN-CLASS (0 ChEMBL) target with A+ grade binding affinity (-8.8 kcal/mol). The mechanistic hypothesis (PIWIL2 → piRNA → transposon silencing → stem cell maintenance) provides a clear therapeutic rationale for Prostate / Pancreatic. Eliminate cancer stem cells driving recurrence. Recommended for wet lab validation.

MindNetQ Inc. — Governed Intelligence for Precision Medicine
Report generated by Cortex autonomous discovery pipeline. All decisions ledger-hashed.